Leaders from the biopharmaceutical industry, academia and government attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, academia, clinical research organizations, and government.
This conference provides attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products.
Key Subjects Include:
- Clinical Trial Study Design
- Trends in Pain Research
- Novel Pain Drug Targets
- Genetic Components of Pain
- Emerging Pain Drug Candidates
- Pain Biomarkers
Industry Early Bird Rate: USD 1395.0,
Academic Early Bird Rate: USD 595.0
Speakers: Keynote Speaker: Walter Koroshetz, MD, Director, National Institute of Neurological Disorders and Stroke